ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 684,82
1,27%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neuralstem Inc (CUR)

  7. Neuralstem Inc (CUR) Actualités

CUR

Neuralstem (CUR)

Neuralstem Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CUR
DateHeureSourceTitreSymboleSociété
19/03/202118h15GlobeNewswire Inc.NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...NASDAQ:CURNeuralstem Inc
02/09/202014h00PR Newswire (US)Letter from Seneca Biopharma's Executive ChairmanNASDAQ:CURNeuralstem Inc
27/05/202017h00PR Newswire (US)Seneca Biopharma Announces the Closing of its $5 Million Registered Direct OfferingNASDAQ:CURNeuralstem Inc
04/11/201922h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
31/10/201916h00PR Newswire (US)Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCANASDAQ:CURNeuralstem Inc
30/10/201912h00PR Newswire (US)Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...NASDAQ:CURNeuralstem Inc
29/10/201904h24PR Newswire (US)Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership SummitNASDAQ:CURNeuralstem Inc
28/10/201914h00PR Newswire (US)Neuralstem Becomes Seneca BiopharmaNASDAQ:CURNeuralstem Inc
12/10/201901h34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
12/10/201901h32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CURNeuralstem Inc
12/10/201901h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
03/10/201915h31PR Newswire (US)Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)NASDAQ:CURNeuralstem Inc
24/09/201913h30PR Newswire (US)Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...NASDAQ:CURNeuralstem Inc
14/08/201913h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CURNeuralstem Inc
14/08/201913h30PR Newswire (US)Neuralstem Reports Second Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
09/08/201915h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CURNeuralstem Inc
07/08/201913h30PR Newswire (US)Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued ListingNASDAQ:CURNeuralstem Inc
31/07/201913h30PR Newswire (US)Neuralstem Closes $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
29/07/201922h47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CURNeuralstem Inc
26/07/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CURNeuralstem Inc
26/07/201904h40PR Newswire (US)Neuralstem Announces Pricing of $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
25/07/201912h05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:CURNeuralstem Inc
22/07/201912h17Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:CURNeuralstem Inc
18/07/201913h30PR Newswire (US)Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of DirectorsNASDAQ:CURNeuralstem Inc
16/07/201913h30PR Newswire (US)Neuralstem Announces a 1-for-20 Reverse Stock SplitNASDAQ:CURNeuralstem Inc
03/07/201923h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CURNeuralstem Inc
01/07/201922h30PR Newswire (US)Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke ...NASDAQ:CURNeuralstem Inc
21/06/201923h14Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CURNeuralstem Inc
16/05/201913h07PR Newswire (US)Neuralstem Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem CellsNASDAQ:CURNeuralstem Inc
14/05/201922h30PR Newswire (US)Neuralstem Reports First Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
 Showing the most relevant articles for your search:NASDAQ:CUR

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
BEL20
Bel 20
EU
ORA
Orange
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
EU
AF
Air FranceKLM
NYSE
KO
Coca Cola
FTSE
UKX
FTSE 100
EU
DG
Vinci
EU
AI
Air Liquide
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés